InvestorsHub Logo
Followers 14
Posts 1735
Boards Moderated 0
Alias Born 01/21/2014

Re: Doc logic post# 57486

Monday, 03/21/2016 2:06:25 PM

Monday, March 21, 2016 2:06:25 PM

Post# of 727366

The issue of dilution with regard to fiduciary duty in the light of success would be put along side of the potential reward from maintaining independence from dilutionary agreements with others. The case against NWBO would be very subjective and difficult to prove.

I disagree. You are assuming there would be dilutionary agreements with others. Judging by the way other companies operate, it seems that a simple raise and pay may have been a much better option than a pay plus equity that is continually topped up for anti-dilution purposes. This Management Team is to act on behalf of the company and it's shareholders. If they are simply looking out for themselves (Cognate), it would be quite easy to prove. They aren't the first company to run a clinical trial......and it really is amazing how much money they spend in comparison to similar companies in similar stages.

Hey Doc I'm just curious, you don't have any relation to NWBO or it's employees do you?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News